Pharmaceuticals and Medical Products
Pharmaceutical companies are tasked with providing life-saving drugs. Assuras helps you achieve this goal by unleashing innovation through digital technology while speeding up drug development and approvals processes.
In spite of all the technological advancements, medical technologies still pose some challenges. That's where Assuras steps in - we take care of those challenges using deep industry knowledge and a range of products.
Most Recent Pharmaceuticals and Medical Products Statistics
➔ In 2018, the global pharmaceuticals market was worth an estimated $1.2 trillion.
➔ The United States is the largest pharmaceuticals market in the world, with sales totaling $459 billion in 2018.
➔ China is the second largest market, with sales of $122 billion in 2018.
➔ The European Union is the third largest market, with sales of $265 billion in 2018.
➔ The pharmaceuticals industry is expected to grow at a compound annual growth rate of 4.4% from 2018 to 2023, reaching a market value of $1.6 trillion by 2023.
Our Contribution — Services
Assuras offers a wide range of services in the Pharmaceuticals And Medical Products industry, including:
- A wide range of innovative services for the pharmaceutical and medical products sector
- A comprehensive approach to quality assurance and regulatory compliance
- Tech deployment for speeding up drug development processes
- Streamlining of clinical trial operations
- Increasing patient safety and efficacy of treatments
- Reducing the cost and time of bringing new drugs and medical products to market
Current State of Industry
The digital transformation of the pharmaceutical industry is well underway. Companies are digitizing their operations and business models to remain competitive and meet the needs of patients and healthcare providers. Many pharmaceutical companies are investing in digital health, data and analytics, and artificial intelligence (AI).
Digital health technologies are being used to improve patient outcomes, lower costs, and increase access to care. Data and analytics are being used to optimize clinical trials, develop new drugs and therapies, and commercialize products. AI is being used to identify new targets for drug discovery, design better clinical trials, and improve patient outcomes.
The pharmaceutical industry is under pressure to meet the needs of patients and healthcare providers in a rapidly changing digital world. But companies are rising to the challenge and are investing in the technologies and capabilities needed to succeed in the digital age.
The Pharmaceuticals industry is under pressure to innovate in order to remain competitive. In particular, the industry must adopt digital technologies in order to remain relevant and to appeal to the new generation of customers.
The industry is currently undergoing a digital transformation, with many companies investing in digital technologies such as artificial intelligence (AI), big data, and the Internet of Things (IoT). These technologies are expected to revolutionize the way drugs are developed and marketed, as well as the way patients are treated.
AI, in particular, is expected to play a major role in the future of the Pharmaceuticals industry. AI can be used to develop new drugs faster and more efficiently, as well as to identify patients who are most likely to respond to a particular treatment. AI can also be used to improve clinical trials, by helping to identify which patients are most likely to respond positively to a particular drug.
Talent management consultancy has emerged as a pivotal force, reshaping how organizations attract, develop, and retain top talent. This transformation is underscored by a recent
Employee engagement is a vital indicator of a healthy workplace. It’s not just about job satisfaction; it’s about how invested employees are in the company’s
Employee engagement has become a top priority for many organizations. Studies show that companies with high levels of engagement outperform their competitors in key areas
Organizational culture encompasses the collective behaviors, assumptions, values and norms that influence how work gets done. It shapes everything from communication and collaboration to the
Organizational culture, often referred to as the “DNA” of a company, dictates how employees interact, make decisions, and approach their work. In modern corporations, where
Mergers and acquisitions (M&A) are often seen as the epitome of corporate strategy, offering companies the opportunity to expand market share, acquire new capabilities, or
Integrated Communication is a strategic approach that synchronizes and coordinates various communication channels—such as public relations, marketing, advertising, and social media—to convey a consistent and
The success of any organizational change is heavily dependent on how well it is communicated within the company. According to a Towers Watson study, ineffective
The retail industry is characterized by increasingly slim profit margins, intense competition, and highly informed customers with ever-changing expectations. In such a high-stakes environment, operational
In an industry where the stakes are sky-high, every second and every cent count. The pharmaceutical sector is a giant maze of intricate processes and
According to a survey conducted by the Business Continuity Institute, nearly 70% of companies experienced at least one supply chain disruption in the past year,
Lean Management Philosophy has been a transformative force across multiple industries, from manufacturing to healthcare. Central to this philosophy is the concept of “visual management,”
Navigating the Landscape of Mergers and Acquisitions in the Pharmaceutical Industry: Trends and Insights
The pharmaceutical industry is undergoing significant changes, with mergers and acquisitions (M&A) playing a pivotal role in shaping its future. Understanding the motivations behind these
Mergers and acquisitions (M&A) have gained substantial popularity as strategies for organizational expansion and growth. However, despite their prevalence, fewer than 20 percent of these
Operational efficiency is the backbone of success in the modern banking sector. As financial institutions navigate a rapidly changing landscape, the ability to streamline processes,
Enterprise Resource Planning (ERP) systems play a pivotal role in modern business operations, enabling companies to streamline processes, improve efficiency, and enhance decision-making. However, implementing
Mergers and acquisitions (M&A) are complex transactions that involve the consolidation of two or more companies to create a larger, more competitive entity. However, before
Change Advisory Boards (CABs) are an essential part of the change management process. They provide support to change management teams by advising on requested changes,
In the past decade, there has been a dramatic shift in the way consumers shop for products. With the advent of technology and social media,
Mergers and acquisitions (M&A) have been a common strategy for banks to expand their operations, acquire new capabilities, and stay competitive in the market. In
Without proper strategic direction, companies can fail without knowing what it was they did wrong. One moment could determine whether or not a company is profitable because these huge corporations are fighting tooth and nail over money; this means that customers need to stay loyal at all costs if they want the chance to win.